Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01051960
Recruitment Status : Completed
First Posted : January 20, 2010
Last Update Posted : March 7, 2018
Gilead Sciences
Information provided by (Responsible Party):
Rajan Saggar, University of California, Los Angeles